0

526546

CHOKSILA

img img img img
No Data Available

CHOKSI LABORATORIES LTD. Share Price Update

As of the latest trading session, CHOKSI LABORATORIES LTD. is trading at ₹99.6, down by ₹-0.05 or -0.05% from its previous close. The stock has moved between ₹98.35 and ₹104.95 today. Over the past year, the stock has delivered a return of -13.42%. In the last month, it has returned 1.63%.

Investment Returns

Over 1 Month 1.63% Over 3 Months -14.32% Over 6 Months -26.87% Over 1 Year -13.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CHOKSI LABORATORIES LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 69.40
  • P/E Ratio (TTM) 37.30
  • Beta 0.53
  • Book Value / share 35.16
  • Return on equity 6.63%
  • EPS (TTM) 2.29
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.31
info icon alternate text

CHOKSI LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 10.82
Operating Expense 10.83
Net Profit 0.31
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.45
EBITDA 3.54
Effective Tax Rate (%) 65.55
Particulars SEP 2025 (Values in Cr)
Revenue 11.12
Operating Expense 10.57
Net Profit 0.24
Net Profit Margin (%) 2.15
Earnings Per Share (EPS) 0.35
EBITDA 2.94
Effective Tax Rate (%) 57.14
Particulars JUN 2025 (Values in Cr)
Revenue 11.24
Operating Expense 10.62
Net Profit 0.39
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.55
EBITDA 2.91
Effective Tax Rate (%) 38.09
Particulars MAR 2025 (Values in Cr)
Revenue 11.40
Operating Expense 10.18
Net Profit 0.92
Net Profit Margin (%) 8.07
Earnings Per Share (EPS) 1.32
EBITDA 3.54
Effective Tax Rate (%) 26.98
Particulars DEC 2024 (Values in Cr)
Revenue 10.38
Operating Expense 10.20
Net Profit 0.11
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.15
EBITDA 2.55
Effective Tax Rate (%) 44.44
Particulars MAR 2025 (Values in Cr)
Revenue 41.78
Operating Expense 39.69
Net Profit 1.52
Net Profit Margin (%) 3.63
Earnings Per Share (EPS) 2.19
EBITDA 11.30
Effective Tax Rate (%) 29.30
Particulars MAR 2024 (Values in Cr)
Revenue 36.70
Operating Expense 35.19
Net Profit 1.11
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 1.59
EBITDA 10.37
Effective Tax Rate (%) 33.13
Particulars MAR 2023 (Values in Cr)
Revenue 34.44
Operating Expense 33.19
Net Profit 3.21
Net Profit Margin (%) 9.32
Earnings Per Share (EPS) 4.61
EBITDA 12.71
Effective Tax Rate (%) 13.70
Particulars MAR 2022 (Values in Cr)
Revenue 30.04
Operating Expense 29.80
Net Profit 0.21
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.30
EBITDA 9.01
Effective Tax Rate (%) 43.24
Particulars MAR 2021 (Values in Cr)
Revenue 25.69
Operating Expense 28.98
Net Profit -2.61
Net Profit Margin (%) -10.15
Earnings Per Share (EPS) -3.74
EBITDA 4.56
Effective Tax Rate (%) 7.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 33.89
ROE % 6.63
ROCE % 8.89
Total Debt to Total Equity 1.31
EBITDA Margin 27.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.89
ROE % 5.12
ROCE % 8.58
Total Debt to Total Equity 1.46
EBITDA Margin 28.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.31
ROE % 8.41
ROCE % 8.92
Total Debt to Total Equity 1.79
EBITDA Margin 30.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 25.70
ROE % 1.18
ROCE % 6.29
Total Debt to Total Equity 2.14
EBITDA Margin 30.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.48
ROE % -13.74
ROCE % 0.02
Total Debt to Total Equity 1.86
EBITDA Margin 17.94
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 65.33
Total Liabilities 65.33
Total Equity 23.60
Share Outstanding 0
Price to Book Ratio 3.55
Return on Assets (%) 2.33
Return on Capital (%) 2.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.65
Total Assets 61.95
Total Liabilities 61.95
Total Equity 22.21
Share Outstanding 0
Price to Book Ratio 1.33
Return on Assets (%) 1.79
Return on Capital (%) 2.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 60.36
Total Liabilities 60.36
Total Equity 21.10
Share Outstanding 0
Price to Book Ratio 1.10
Return on Assets (%) 5.31
Return on Capital (%) 6.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 64.41
Total Liabilities 64.41
Total Equity 17.90
Share Outstanding 0
Price to Book Ratio 0.99
Return on Assets (%) 0.32
Return on Capital (%) 0.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 66.38
Total Liabilities 66.38
Total Equity 17.74
Share Outstanding 0
Price to Book Ratio 0.31
Return on Assets (%) -3.92
Return on Capital (%) -4.83
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 13.77
Cash from Investing -7.60
Cash from Financing -4.21
Net change in Cash -0.04
Free Cash Flow 21.21
Particulars MAR 2024 (Values in Cr)
Net Income 1.66
Cash from Operations 12.04
Cash from Investing -6.64
Cash from Financing -4.58
Net change in Cash 0.31
Free Cash Flow 16.39
Particulars MAR 2023 (Values in Cr)
Net Income 3.72
Cash from Operations 7.50
Cash from Investing -0.70
Cash from Financing -7.61
Net change in Cash -0.06
Free Cash Flow 11.44
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations 6.70
Cash from Investing -2.70
Cash from Financing -5.06
Net change in Cash 0.10
Free Cash Flow 7.68
Particulars MAR 2021 (Values in Cr)
Net Income -2.80
Cash from Operations 2.78
Cash from Investing -7.64
Cash from Financing 1.62
Net change in Cash -0.11
Free Cash Flow 10.33
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8094.85 64.08 12.81 116391.52 6680.00 8114.00
FORTIS MALAR HOSPITALS LIMITED 57.32 23.69 3.12 107.43 40.75 81.00
SHREE PACETRONIX LTD. 137.10 20.68 3.02 51.41 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.55 23.49 1.83 5.26
VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8094.85 80.14 12.49 116391.52 6680.00 8114.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.00 0.00 -11.04 28.39 30.02 57.48
KOVAI MEDICAL CENTER & HO 5674.75 26.33 5.21 6208.18 5010.00 6725.00

CHOKSI LABORATORIES LTD. shareholding pattern

Holding
62.48%
31.48%
6.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

CHOKSI LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
99.60 -0.05 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 100.20
  • 26 Days 101.60
  • 10 Days 100.70
  • 50 Days 104.20
  • 12 Days 100.90
  • 100 Days 113.10
  • 20 Days 101.20
  • 200 Days 123.50
103.23 PIVOT
First Support 93.57 First Resistance 109.32 Second Support 87.48 Second Resistance 118.98 Third Support 77.82 Third Resistance 125.07
RSI 46.31 ADX 12.82 MACD -0.72 Williams % R -73.17 Commodity Channel Index (CCI) -11.36
Date 2026-05-08 Week 1982.00 Same Day 1170.00 Month 1507.00
1 Year 0.53 3 Year 0.84
Over 1 Month
1.63% down
Over 1 Year
-13.42% down
Over 3 Months
-14.32% down
Over 3 Years
30.81% down
Over 6 Months
-26.87% down
Over 5 Years
58.36% down

CHOKSI LABORATORIES LTD. Corporate Actions

Top Gainers

Top Losers

CHOKSI LABORATORIES LTD. Share Price

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services. CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries. The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.

The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day. It provides calibration of production & quality control equipment with traceability to national / international standards. This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects. This requires a detailed knowledge of the industry sector as well as the client's business processes. CLL has expertise in setting up in-house labs for a large number of clients, which provide consultancy, training & independent auditing for Quality Management Systems.

The Company started its unit at Vapi (Gujarat) and also got registered with FDA department during 2002. It started the laboratory at Chandigarh in 2005; thereafter the Goa Lab in 2011 and calibration of Bangalore operation from May 2011.

Company has received enhanced CDSCO approval for testing 69 types of medical devices in FY 2024.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Choksi Laboratories Ltd?

Answer Field

Choksi Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 99.60 as on May 08 2026 03:30 PM.

What is the Market Cap of Choksi Laboratories Ltd Share?

Answer Field

The market cap of Choksi Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 69.40 as on May 08 2026 03:30 PM.

What is the 52 Week High and Low of Choksi Laboratories Ltd?

Answer Field

The 52 Week High and Low of Choksi Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 236.70 and ₹ 81.85.

What is 1 year return for Choksi Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -13.42%.

What is the P/E Ratio of Choksi Laboratories Ltd Share?

Answer Field

As on May 08 2026 03:30 PM the price-to-earnings (PE) ratio for Choksi Laboratories Ltd share is 37.30.

What is the PB ratio of Choksi Laboratories Ltd Share?

Answer Field

As on May 08 2026 03:30 PM, the price-to-book (PB) ratio for Choksi Laboratories Ltd share is 35.16.

How to Buy Choksi Laboratories Ltd Share?

Answer Field

You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Choksi Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Choksi Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Choksi Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|